A detailed history of Riverview Capital Advisers, LLC transactions in Stryker Corp stock. As of the latest transaction made, Riverview Capital Advisers, LLC holds 4,420 shares of SYK stock, worth $1.59 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
4,420
Previous 4,445 0.56%
Holding current value
$1.59 Million
Previous $1.59 Million 5.47%
% of portfolio
0.52%
Previous 0.57%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$324.3 - $354.67 $8,107 - $8,866
-25 Reduced 0.56%
4,420 $1.5 Million
Q4 2023

Feb 12, 2024

BUY
$253.85 - $299.46 $5,077 - $5,989
20 Added 0.45%
4,445 $1.33 Million
Q2 2023

Aug 04, 2023

BUY
$271.49 - $305.09 $1,085 - $1,220
4 Added 0.09%
4,425 $1.35 Million
Q3 2022

Feb 07, 2023

BUY
$189.27 - $231.83 $19,116 - $23,414
101 Added 2.34%
4,421 $895 Million
Q4 2021

Feb 07, 2023

BUY
$236.63 - $276.44 $1.02 Million - $1.19 Million
4,320 New
4,320 $1.16 Billion

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $136B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Riverview Capital Advisers, LLC Portfolio

Follow Riverview Capital Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Capital Advisers, LLC with notifications on news.